Amgen Inc. (AMGN)

USD 258.78

(-2.7%)

Total Assets Summary of Amgen Inc.

  • Amgen Inc.'s latest annual total assets in 2023 was 97.15 Billion USD , up 49.19% from previous year.
  • Amgen Inc.'s latest quarterly total assets in 2024 Q2 was 90.9 Billion USD , down -2.23% from previous quarter.
  • Amgen Inc. reported annual total assets of 65.12 Billion USD in 2022, up 6.47% from previous year.
  • Amgen Inc. reported annual total assets of 61.16 Billion USD in 2021, down -2.83% from previous year.
  • Amgen Inc. reported quarterly total assets of 90.9 Billion USD for 2024 Q2, down -2.23% from previous quarter.
  • Amgen Inc. reported quarterly total assets of 90.88 Billion USD for 2024 Q3, down -0.03% from previous quarter.

Annual Total Assets Chart of Amgen Inc. (2023 - 1990)

Historical Annual Total Assets of Amgen Inc. (2023 - 1990)

Year Total Assets Total Assets Growth
2023 97.15 Billion USD 49.19%
2022 65.12 Billion USD 6.47%
2021 61.16 Billion USD -2.83%
2020 62.94 Billion USD 5.43%
2019 59.7 Billion USD -10.1%
2018 66.41 Billion USD -16.93%
2017 79.95 Billion USD 3.0%
2016 77.62 Billion USD 8.45%
2015 71.57 Billion USD 3.72%
2014 69 Billion USD 4.36%
2013 66.12 Billion USD 21.78%
2012 54.29 Billion USD 11.1%
2011 48.87 Billion USD 12.38%
2010 43.48 Billion USD 9.73%
2009 39.62 Billion USD 8.74%
2008 36.44 Billion USD 5.21%
2007 34.63 Billion USD 2.52%
2006 33.78 Billion USD 15.33%
2005 29.29 Billion USD 0.26%
2004 29.22 Billion USD 11.63%
2003 26.17 Billion USD 7.03%
2002 24.45 Billion USD 279.57%
2001 6.44 Billion USD 19.33%
2000 5.39 Billion USD 32.42%
1999 4.07 Billion USD 11.04%
1998 3.67 Billion USD 18.07%
1997 3.11 Billion USD 12.46%
1996 2.76 Billion USD 13.68%
1995 2.43 Billion USD 22.0%
1994 1.99 Billion USD 12.95%
1993 1.76 Billion USD 28.47%
1992 1.37 Billion USD 58.79%
1991 865.5 Million USD 180.92%
1990 308.1 Million USD 0.0%

Peer Total Assets Comparison of Amgen Inc.

Name Total Assets Total Assets Difference
AstraZeneca PLC 101.11 Billion USD 3.921%
Biogen Inc. 26.84 Billion USD -261.91%
Gilead Sciences, Inc. 62.12 Billion USD -56.385%
MIRA Pharmaceuticals, Inc. 4.93 Million USD -1969593.314%
Scilex Holding Company 101.3 Million USD -95798.686%
Scilex Holding Company 101.3 Million USD -95798.686%